Development of Classification Model batteries for predicting inhibition of tubulin polymerization by small molecules

Abstract The development of two classification model (CM) batteries capable of discerning the ability of small molecules to inhibit tubulin polymerization is described. Approximately 550 compounds collected from the literature were utilized to calculate approximately 1000 molecular descriptors. After randomly culling 50 compounds to serve as a subsequent prediction set (PS) for validation, the remainder was used to set up two datasets, one where molecules were considered active or not with an IC50 threshold of 10 μM and the other with an IC50 threshold of 1 μM. Each dataset was rationally split into training sets (TR) and test sets (TS). Several hundred CMs were obtained using different TR sets, many different “decision tree” algorithms and different end-point thresholds for binary classification. The relevant TS sets were used to assess model performance and to reduce the number of models to 15 for each of the two IC50-threshold datasets. The rigorously validated models were further tested for their predictive capability on the prediction set. Although individual models that proved to have the best predictive capability would be useful, we found that using the entire battery of 15 models for each of the datasets strengthens the predictive power significantly — approaching 100% certainty for molecules within the applicability domain of the models. These CM batteries should be quite valuable to assess the potential any new chemical entity proposed for synthesis as an inhibitor of tubulin polymerization in an anticancer drug discovery program.

[1]  T. Tsuruo,et al.  Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. , 1996, Cancer research.

[2]  T. Yamori,et al.  Synthesis and Biological Evaluation of Boronic Acid Containing cis‐Stilbenes as Apoptotic Tubulin Polymerization Inhibitors , 2006, ChemMedChem.

[3]  R. Gambari,et al.  Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. , 2006, Journal of medicinal chemistry.

[4]  P. Renard,et al.  Novel benzopyridothiadiazepines as potential active antitumor agents. , 2005, Journal of medicinal chemistry.

[5]  D. Kingston,et al.  Syntheses and bioactivities of macrocyclic paclitaxel bis-lactones. , 2004, Bioorganic & medicinal chemistry.

[6]  S. Kasibhatla,et al.  Discovery of substituted 4-anilino-2-(2-pyridyl)pyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. Part 1: structure-activity relationships of the 4-anilino group. , 2006, Bioorganic & medicinal chemistry.

[7]  G. Giannini,et al.  Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. , 2005, Journal of medicinal chemistry.

[8]  Y. Koiso,et al.  Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. , 1998, Bioorganic & medicinal chemistry letters.

[9]  V. Villalobos,et al.  Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin. , 2000, Bioorganic & medicinal chemistry.

[10]  A. Brossi,et al.  Antitumor agents. Part 226: synthesis and cytotoxicity of 2-phenyl-4-quinolone acetic acids and their esters. , 2003, Bioorganic & medicinal chemistry letters.

[11]  Andrea Brancale,et al.  New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies. , 2006, Journal of medicinal chemistry.

[12]  Yoav Freund,et al.  The Alternating Decision Tree Learning Algorithm , 1999, ICML.

[13]  João Aires-de-Sousa,et al.  Prediction of enantioselectivity using chirality codes and Classification and Regression Trees , 2005 .

[14]  S. Mooberry,et al.  Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. , 1999, Cancer research.

[15]  P. Corchete,et al.  Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins. , 2007, Bioorganic & medicinal chemistry letters.

[16]  E. Hamel,et al.  Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. , 1988, Molecular pharmacology.

[17]  A. Tropsha,et al.  Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysis. , 2000, Journal of medicinal chemistry.

[18]  Weikang Tao,et al.  Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. , 2005, Cancer cell.

[19]  Concepción Pérez-Melero,et al.  New naphthylcombretastatins. Modifications on the ethylene bridge. , 2005, Bioorganic & medicinal chemistry.

[20]  E. Günther,et al.  Design and Synthesis of a Focused Library of Novel Aryl‐ and Heteroaryl‐Ketopiperazides , 2004, Archiv der Pharmazie.

[21]  Alessandro Pedretti,et al.  VEGA – An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming , 2004, J. Comput. Aided Mol. Des..

[22]  H. Hsieh,et al.  4- and 5-aroylindoles as novel classes of potent antitubulin agents. , 2007, Journal of medicinal chemistry.

[23]  Mathias Schmidt,et al.  Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[24]  T. Barlozzari,et al.  LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. , 1995, Cancer research.

[25]  S. Ng,et al.  A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. , 2001, Cancer research.

[26]  D. Sackett,et al.  Tubulysin analogs incorporating desmethyl and dimethyl tubuphenylalanine derivatives. , 2008, Bioorganic & Medicinal Chemistry Letters.

[27]  R. Peláez,et al.  A new family of quinoline and quinoxaline analogues of combretastatins. , 2004, Bioorganic & medicinal chemistry letters.

[28]  Robert D. Clark,et al.  OptiSim: An Extended Dissimilarity Selection Method for Finding Diverse Representative Subsets , 1997, J. Chem. Inf. Comput. Sci..

[29]  A. Brossi,et al.  Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors. , 1998, Journal of medicinal chemistry.

[30]  Anna Ivana Scovassi,et al.  Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies. , 2007, Journal of medicinal chemistry.

[31]  Y. Hitoshi,et al.  R-253 Disrupts Microtubule Networks in Multiple Tumor Cell Lines , 2006, Clinical Cancer Research.

[32]  S. Kuo,et al.  Synthesis and Biological Evaluation of 6 , 7 , 2 ′ , 3 ′ , 4 ′-Substituted-1 , 2 , 3 , 4-tetrahydro-2-phenyl-4-quinolones as a New Class of Antimitotic Antitumor Agents , 1998 .

[33]  William E. Kemnitzer,et al.  Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. , 2004, Journal of medicinal chemistry.

[34]  P Willett,et al.  Comparison of algorithms for dissimilarity-based compound selection. , 1997, Journal of molecular graphics & modelling.

[35]  H. Harn,et al.  In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. , 2006, Biochemical pharmacology.

[36]  Scott D. Kahn,et al.  Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.

[37]  Geoff Holmes,et al.  Multiclass Alternating Decision Trees , 2002, ECML.

[38]  H. Hsieh,et al.  7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents. , 2006, Journal of medicinal chemistry.

[39]  A. Malikzay,et al.  Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines. , 2006, Bioorganic & medicinal chemistry letters.

[40]  T. Owa,et al.  Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis. , 2002, Molecular cancer therapeutics.

[41]  Igor V. Tetko,et al.  Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..

[42]  Igor V Tetko,et al.  Computing chemistry on the web. , 2005, Drug discovery today.

[43]  Thomas G. Dietterich An Experimental Comparison of Three Methods for Constructing Ensembles of Decision Trees: Bagging, Boosting, and Randomization , 2000, Machine Learning.

[44]  G. Jasso Review of "International Encyclopedia of Statistical Sciences, edited by Samuel Kotz, Norman L. Johnson, and Campbell B. Read, New York, Wiley, 1982-1988" , 1989 .

[45]  Andrea Brancale,et al.  Arylthioindoles, potent inhibitors of tubulin polymerization. , 2004, Journal of medicinal chemistry.

[46]  Y. Kuo,et al.  Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. , 2004, Molecular pharmacology.

[47]  A. Mannschreck,et al.  Inhibition of tubulin polymerization by 5,6-dihydroindolo[2,1-alpha]isoquinoline derivatives. , 1997, Journal of medicinal chemistry.

[48]  F. Mollinedo,et al.  Microtubules, microtubule-interfering agents and apoptosis , 2003, Apoptosis.

[49]  J. Doroshow,et al.  Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel , 2004, Clinical Cancer Research.

[50]  Brian D. Hudson,et al.  Parameter Based Methods for Compound Selection from Chemical Databases , 1996 .

[51]  M. Boyd,et al.  Antineoplastic agents. 379. Synthesis of phenstatin phosphate. , 1998, Journal of medicinal chemistry.

[52]  E. De Clercq,et al.  Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles. , 2005, Bioorganic & medicinal chemistry letters.

[53]  F. Mollinedo,et al.  Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety. , 2005, Journal of medicinal chemistry.

[54]  B. Sikic,et al.  Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  Osman A. B. S. M. Gani,et al.  1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. , 2008, Bioorganic & medicinal chemistry.

[56]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .

[57]  S. Thoret,et al.  Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10. , 1998, Bioorganic & medicinal chemistry letters.

[58]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[59]  J. Wdzieczak‐Bakala,et al.  New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. , 2008, Journal of medicinal chemistry.

[60]  S. Srivastava,et al.  Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents. , 2007, Journal of medicinal chemistry.

[61]  Desire L. Massart,et al.  Classification and Regression Trees-Studies of HIV Reverse Transcriptase Inhibitors , 2004, J. Chem. Inf. Model..

[62]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[63]  Jeffrey R. Jackson,et al.  Targeted anti-mitotic therapies: can we improve on tubulin agents? , 2007, Nature Reviews Cancer.

[64]  G. Klebe,et al.  Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors. , 2006, Journal of medicinal chemistry.

[65]  A K Chakraborti,et al.  Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. , 1991, Journal of medicinal chemistry.

[66]  Yvan Vander Heyden,et al.  Classification Tree Models for the Prediction of Blood-Brain Barrier Passage of Drugs , 2006, J. Chem. Inf. Model..

[67]  S. Kasibhatla,et al.  Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay. , 2003, Journal of medicinal chemistry.

[68]  A. Brancale,et al.  Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization. , 2008, Bioorganic & medicinal chemistry letters.

[69]  Austin J. Peck,et al.  Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. , 2004, Biochemistry.

[70]  S. Steinberg,et al.  Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  Deepak Sampath,et al.  Preclinical Pharmacologic Evaluation of MST-997, an Orally Active Taxane with Superior In vitro and In vivo Efficacy in Paclitaxel- and Docetaxel-Resistant Tumor Models , 2006, Clinical Cancer Research.

[72]  Gordon M. Crippen,et al.  Use of Classification Regression Tree in Predicting Oral Absorption in Humans , 2004, J. Chem. Inf. Model..

[73]  T. Fojo,et al.  Tubulin/microtubules: still a promising target for new chemotherapeutic agents. , 2000, Journal of the National Cancer Institute.

[74]  C. Fairchild,et al.  Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). , 1998, Cancer research.

[75]  A. Bianucci,et al.  Quantitative Structure–Activity Relationship Models for Predicting Biological Properties, Developed by Combining Structure‐ and Ligand‐Based Approaches: An Application to the Human Ether‐a‐go‐go‐Related Gene Potassium Channel Inhibition , 2009, Chemical biology & drug design.

[76]  D L Massart,et al.  Classification of drugs in absorption classes using the classification and regression trees (CART) methodology. , 2005, Journal of pharmaceutical and biomedical analysis.

[77]  F. Meng,et al.  Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles. , 2007, Journal of medicinal chemistry.

[78]  Y. Koiso,et al.  Ustiloxins, new antimitotic cyclic peptides: interaction with porcine brain tubulin. , 1995, Biochemical pharmacology.

[79]  Ramaswamy Nilakantan,et al.  Database diversity assessment: New ideas, concepts, and tools , 1997, J. Comput. Aided Mol. Des..

[80]  Peter Schmidt,et al.  Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. , 2007, Journal of medicinal chemistry.

[81]  N. Lawrence,et al.  Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.

[82]  H. Hsieh,et al.  Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. , 2004, Journal of medicinal chemistry.

[83]  H. Rosenkranz,et al.  Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. , 1996, Bioorganic & medicinal chemistry.